Evidence map›Paper›PMID 30295347›Full record

ArticleAnnals of neurology2018

KCTD7 deficiency defines a distinct neurodegenerative disorder with a conserved autophagy-lysosome defect.

Kyle A Metz, Xinchen Teng, Isabelle Coppens, Heather M Lamb, Bart E Wagner, Jill A Rosenfeld, Xianghui Chen, Yu Zhang, Hee Jong Kim, Michael E Meadow and 33 more

Open access · greenAbstract read
In one paragraph

Article in Annals of neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 58 citations in OpenAlex.

  1. Identification of a Novel homozygous Splice-Site Deletion inPakistan journal of medical sciences · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. KCTD10 regulates brain development by destabilizing brain disorder-associated protein KCTD13.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

43 authors at 20 institutions in 8 countries.

Kyle A MetzDepartment of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD.
Xinchen TengDepartment of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD.
Isabelle CoppensDepartment of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD.
Heather M LambDepartment of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD.
Bart E WagnerHistopathology Department, Royal Hallamshire Hospital, Sheffield, United Kingdom.
Jill A RosenfeldDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.ORCID 0000-0001-5664-7987
Xianghui ChenJiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu Province, People's Republic of China.
Yu ZhangJiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu Province, People's Republic of China.
Hee Jong KimDepartment of Biological Chemistry, David Geffen School of Medicine at UCLA, Los Angeles, CA.
Michael E MeadowDepartment of Biological Chemistry, David Geffen School of Medicine at UCLA, Los Angeles, CA.
Tim Sen WangDepartment of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD.
Edda D HaberlandtClinical Department of Pediatrics I, Innsbruck Medical University, Innsbruck, Austria.
Glenn W AndersonHistopathology Department, Great Ormond Street Hospital for Children, London, United Kingdom.
Esther Leshinsky-SilverMolecular Genetics Laboratory, Wolfson Medical Center, Holon, Israel.
Weimin BiDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.
Thomas C MarkelloNIH Undiagnosed Diseases Program, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD.
Marsha PrattDepartment of Pediatrics, University of Oklahoma College of Medicine, Oklahoma City, OK.
Nawal MakhseedDepartment of Pediatrics, Jahra Hospital, Ministry of Health, Al Jahra, Kuwait.
Adolfo GarnicaDepartment of Pediatrics, University of Arkansas for Medical Sciences and Arkansas Children's Hospital, Little Rock, AR.
Noelle R DanylchukDepartment of Pediatrics, University of Arkansas for Medical Sciences and Arkansas Children's Hospital, Little Rock, AR.
Thomas A BurrowDepartment of Pediatrics, University of Arkansas for Medical Sciences and Arkansas Children's Hospital, Little Rock, AR.
Parul JayakarDivision of Genetics and Metabolism, Nicklaus Children's Hospital, Miami, FL.
Dianalee McKnightGeneDx, Gaithersburg, MD.
Satish AgadiDepartment of Neurology, Texas Children's Hospital, Houston, TX.
Hatha GbedawoVital Kids Medicine, Seattle, WA.
Christine StanleyCourtagen Life Sciences, Woburn, MA.
Michael AlberPediatric Neurology and Developmental Medicine, University of Tübingen, Tübingen, Germany.
Isabelle PrehlPractice for Human Genetics, CeGaT, Tübingen, Germany.
Katrina PearisoDivision of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Min Tsui OngDepartment of Paediatric Neurology, Sheffield Children's National Health Service Foundation Trust, Sheffield, United Kingdom.
Santosh R MordekarDepartment of Paediatric Neurology, Sheffield Children's National Health Service Foundation Trust, Sheffield, United Kingdom.
Michael J ParkerSheffield Clinical Genetics Service, Sheffield Children's National Health Service Foundation Trust, Sheffield, United Kingdom.
Daniel CrooksDepartment of Neuropathology, Walton Centre National Health Service Foundation Trust, Liverpool, United Kingdom.
Pankaj B AgrawalDivision of Genetics and Genomics, Manton Center for Orphan Disease Research, Boston Children's Hospital, Harvard Medical School, Boston, MA.
Gerard T BerryDivision of Genetics and Genomics, Manton Center for Orphan Disease Research, Boston Children's Hospital, Harvard Medical School, Boston, MA.
Tobias LoddenkemperDepartment of Neurology, Boston Children's Hospital, Boston, MA.
Yaping YangDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.
Gustavo H B MaegawaDepartment of Pediatrics/Genetics and Metabolism, University of Florida, Gainesville, FL.
Abdel AouacheriaMontpellier Institute of Evolution Sciences, University of Montpellier, CNRS, EPHE, IRD, Montpellier, France.ORCID 0000-0001-6712-9595
Janet G MarkleDepartment of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD.
James A WohlschlegelDepartment of Biological Chemistry, David Geffen School of Medicine at UCLA, Los Angeles, CA.
Adam L HartmanDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.ORCID 0000-0001-5672-3409
J Marie HardwickDepartment of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD.ORCID 0000-0002-4847-2045
Johns Hopkins University · USNational Health Service · GBArkansas Children's Hospital · USBaylor College of Medicine · USBoston Children's Hospital · USUniversity of California, Los Angeles · USSoochow University · CNCeGaT (Germany) · DECentre National de la Recherche Scientifique · FRCincinnati Children's Hospital Medical Center · USCourtagen Life Sciences (United States) · USGenVec · USGreat Ormond Street Hospital · GBInnsbruck Medical University · ATJahra Hospital · KWMiami Children's Hospital · USNational Institutes of Health · USOklahoma City University · USRoyal Hallamshire Hospital · GBTexas Children's Hospital · US

Funding

Training: Molecular & Cellular Bases of Infectious DiseasesT32AI007417 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Arturo Casadevall · 1994 to 2026
$11.9M
REGULATION OF BCL XL BY CASPASESR01NS037402 · NINDS · JOHNS HOPKINS UNIVERSITY · PI HARDWICK, J. MARIE · 1999 to 2014
$4.5M
Proteolytic Control of Iron Metabolism by the Ubiquitin Ligase FBXL5R01GM089778 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WOHLSCHLEGEL, JAMES AKIRA · 2010 to 2023
$4.0M
Mechanisms of NeurodegenerationR01NS083373 · NINDS · JOHNS HOPKINS UNIVERSITY · PI HARDWICK, J. MARIE · 2013 to 2017
$1.8M
Conserved Cell Death Pathways in Mammals and YeastR01GM077875 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI HARDWICK, J. MARIE · 2006 to 2010
$1.4M
Mitochodrial Dynamics in Metabolism-based Therapies for EpilepsyK08NS070931 · NINDS · JOHNS HOPKINS UNIVERSITY · PI HARTMAN, ADAM L · 2011 to 2015
$932k
Non-apoptotic caspase activity in neuronsR21NS096677 · NINDS · JOHNS HOPKINS UNIVERSITY · PI HARDWICK, J. MARIE · 2016 to 2017
$439k
CURE, Citizens United for Research in EpilepsyNIAID NIH HHS T32 AI007417NIGMS NIH HHS R01 GM077875NIGMS NIH HHS R01 GM089778NIH HHS K08 NS070931NIH HHS R01 GM089778NIH HHS R01 NS037402NIH HHS R01 NS083373NINDS NIH HHS K08 NS070931NINDS NIH HHS R01 NS037402NINDS NIH HHS R01 NS083373NINDS NIH HHS R21 NS096677
6 · The paper itself

Abstract

objectiveSeveral small case series identified KCTD7 mutations in patients with a rare autosomal recessive disorder designated progressive myoclonic epilepsy (EPM3) and neuronal ceroid lipofuscinosis (CLN14). Despite the name KCTD (potassium channel tetramerization domain), KCTD protein family members lack predicted channel domains. We sought to translate insight gained from yeast studies to uncover disease mechanisms associated with deficiencies in KCTD7 of unknown function.

methodsNovel KCTD7 variants in new and published patients were assessed for disease causality using genetic analyses, cell-based functional assays of patient fibroblasts and knockout yeast, and electron microscopy of patient samples.

resultsPatients with KCTD7 mutations can exhibit movement disorders or developmental regression before seizure onset, and are distinguished from similar disorders by an earlier age of onset. Although most published KCTD7 patient variants were excluded from a genome sequence database of normal human variations, most newly identified patient variants are present in this database, potentially challenging disease causality. However, genetic analysis and impaired biochemical interactions with cullin 3 support a causal role for patient KCTD7 variants, suggesting deleterious alleles of KCTD7 and other rare disease variants may be underestimated. Both patient-derived fibroblasts and yeast lacking Whi2 with sequence similarity to KCTD7 have impaired autophagy consistent with brain pathology.

interpretationBiallelic KCTD7 mutations define a neurodegenerative disorder with lipofuscin and lipid droplet accumulation but without defining features of neuronal ceroid lipofuscinosis or lysosomal storage disorders. KCTD7 deficiency appears to cause an underlying autophagy-lysosome defect conserved in yeast, thereby assigning a biological role for KCTD7. Ann Neurol 2018;84:774-788.

Indexed as

Age of OnsetAutophagyChild, PreschoolFemaleHumansInfantLysosomesMaleMutationNeurodegenerative DiseasesPedigreePotassium ChannelsSaccharomyces cerevisiae ProteinsKCTD7 protein, humanPotassium ChannelsSaccharomyces cerevisiae ProteinsWhi2 protein, S cerevisiae

Identifiers

PMID30295347
PMCPMC6295419
OpenAlexW2896204252

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.